Deepa Bhojwani, MD, joins Children’s Hospital Los Angeles (CHLA) as director of the Leukemia/Lymphoma program within the Children’s Center for Cancer and Blood Diseases on February 15, 2015. She comes to CHLA from St. Jude Children’s Research Hospital where she has been an assistant member since 2008.
Researchers have designed and developed a new protein-based therapy they believe will prove highly effective against drug-resistant leukemia cells. It may also amplify the potency of standard treatment options such as chemotherapy and radiation therapy.
Researchers have shown that neonatal mouse hearts have varying regenerative capacities depending upon the severity of injury. Approaches to extend this regenerative capacity in a mammalian model, from the neonatal period to the juvenile or adult period, could help identify new treatment options for humans.